Diana M. Cejas

Diana M. Cejas, MD, MPH serves as Associate Professor of Neurology at the University of North Carolina at Chapel Hill School of Medicine with a dual appointment at the Carolina Institute of Developmental Disabilities. She is a board-certified specialist in both Pediatrics (2013) and Child Neurology (2017), providing clinical care across multiple UNC Health facilities including UNC Hospitals Children's Specialty Services at Raleigh, the Carolina Institute for Developmental Disabilities in Carrboro, and the UNC Hospitals Children's Neurology Clinic in Chapel Hill.

• Doctor of Medicine, Howard University (2010)
• Masters of Public Health, Maternal and Child Health, George Washington University (2014)
• Pediatric Residency, Tulane University Health Sciences Center (2010-2013)
• Child Neurology Residency, University of Chicago Medical Center (2014-2017)
• Bachelor of Arts in Physics, University of North Carolina at Charlotte (2005)
• Bachelor of Science in Biology, Appalachian State University (2003)

Dr. Cejas specializes in autism spectrum disorders, intellectual disabilities, and neurodevelopmental disabilities with research focusing on healthcare transition for youth with intellectual and neurodevelopmental disabilities, health equity, and patient advocacy for young adults with disabilities. Her clinical expertise centers on providing comprehensive neurological care for children and young adults with developmental conditions, emphasizing equitable access and patient-centered approaches throughout the transition from pediatric to adult healthcare systems.

Her scholarly work demonstrates a consistent focus on diversity, equity, and inclusion within neurology, particularly examining disability perspectives and healthcare transition models. The publications reveal an evolving trajectory from personal reflections on medical practice to active leadership in professional society initiatives addressing systemic issues in neurology.

As an active clinician-educator, Dr. Cejas contributes to the Carolina Institute for Developmental Disabilities and participates in the Epilepsy Neurogenetics Initiative. Her work bridges clinical practice with advocacy, focusing on improving healthcare systems for vulnerable populations with neurodevelopmental conditions.